Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 91Lymphoma, Non-Hodgkin 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 87Leukemia, Lymphocytic, Chronic, B-Cell 70Lymphoma, Large B-Cell, Diffuse 56Lymphoma, Follicular 53Hodgkin Disease 42Burkitt Lymphoma 42Recurrence 39Lymphoma, B-Cell 35Leukemia, Myeloid, Acute 35Multiple Myeloma 34Lymphoma, Mantle-Cell 34Leukemia 34Myelodysplastic Syndromes 24Neoplasms 23Hematologic Neoplasms 21Waldenstrom Macroglobulinemia 17Lymphoma, B-Cell, Marginal Zone 17Leukemia, B-Cell 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Sarcoma 13Lymphoma, T-Cell 12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large-Cell, Anaplastic 11Lymphoma, T-Cell, Peripheral 10Leukemia, Biphenotypic, Acute 10Glioma 10Osteosarcoma 9Neuroblastoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Intellectual Disability × Lymphoid × 30 days × Clear all
NCT07599033 2026-05-22

PAPE-MID

Inonu University

Phase NA Completed
46 enrolled
Lymphoid

Lymphoma, Follicular, Intellectual Disability, Motor Activity

NCT07586722 2026-05-14

PBID-12

Burdur Mehmet Akif Ersoy University

Phase NA Active not recruiting
32 enrolled
Lymphoid

Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡